AMZN
Amazon.com, Inc.
AMZN has the edge over THO overall, supported by stronger modeled upside and stronger valuation.
THO
Thor Industries, Inc.
THO's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
THO Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Under pressure | |
| Healthy |
THO's balance sheet is currently healthy, and its profitability is stable, but its revenue and cash flow are under pressure.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over THO in the historical PE scenario, which offers more potential upside but is not a forecast.
THO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.6x | $18.83 | -76% |
| Fair | 19x | $63.46 | -18% |
| Forward | 20x | $77.29 | — |
| Expensive | 23x | $78.24 | +1.2% |
| Current | 23x | $77.29 | — |
Historical ranges are pointers, not guarantees.
THO's PE is in its expensive range at 23x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
THO Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for THO, with profitability holding steady. However, they disagree widely on these estimates.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over THO on earnings, with more consistent year-over-year improvement.
THO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.92 | +16% |
| Q3 2026 | $3.38 | -30% |
| Q2 2026 | $4.96 | +19% |
| Q1 2026 | $5.63 | +49% |
| Q4 2025 | $5.28 | +35% |
| Q3 2025 | $4.84 | -2% |
| Q2 2025 | $4.18 | -15% |
| Q1 2025 | $3.78 | -25% |
| Q4 2024 | $3.92 | -28% |
THO's earnings per share have fallen from their peak: $3.38 over the past year, against $20.59 in mid-2022.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over THO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over THO on profitability, with a higher operating margin.
THO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.3B | -8.4% |
| Q2 2026 | $2.8B | -3.9% |
| Q1 2026 | $2.1B | +5.3% |
| Q4 2025 | $2.4B | +11% |
| Q3 2025 | $2.5B | -0.4% |
| Q2 2025 | $2.9B | +3.3% |
| Q1 2025 | $2B | -8.6% |
| Q4 2024 | $2.1B | -14% |
THO's revenue fell from its 2022 peak and has held roughly level since: $2.3B last quarter, down 8.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.2% | -3.4 points |
| Q2 2026 | 4.8% | -0.6 points |
| Q1 2026 | 1% | +1.1 points |
| Q4 2025 | 1.4% | +1.4 points |
| Q3 2025 | 5.7% | +0.7 points |
| Q2 2025 | 5.4% | +0.3 points |
| Q1 2025 | -0.1% | -0.4 points |
| Q4 2024 | -0.1% | -2.9 points |
THO's operating margin was 2.2% last quarter, down 3.4 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
THO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $189.9M | -14% |
| Q2 2026 | $196M | -12% |
| Q1 2026 | -$145.2M | -2588% |
| Q4 2025 | -$74.8M | -1270% |
| Q3 2025 | $221.6M | -26% |
| Q2 2025 | $222.5M | -1.3% |
| Q1 2025 | $5.8M | +$146.1M |
| Q4 2024 | $6.4M | -67% |
THO has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
THO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +163K shares |
| 1 year | -1.6% | -838K shares |
| 3 years | -2.4% | -1.3M shares |
| 5 years | -5.6% | -3.1M shares |
| Available history | -4.8% | -2.7M shares |
THO has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $34.3M |
| Q2 2026 | $50.5M |
| Q1 2026 | $25.2M |
| Q4 2025 | $5M |
| Q3 2025 | $50.9M |
| Q2 2025 | — |
| Q1 2025 | $1.7M |
| Q4 2024 | — |
THO spent $115M buying back its own shares over the past year, up 119% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over THO on leverage, with a lower net debt burden relative to earnings.
THO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.8x | Very low |
| Q2 2026 | 0.8x | Very low |
| Q1 2026 | 1.0x | Healthy |
| Q4 2025 | 0.7x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.9x | Very low |
| Q1 2025 | 1.2x | Healthy |
| Q4 2024 | 1.1x | Healthy |
THO's net debt is less than a year of its operating earnings (EBITDA).
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
THO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.9 | Neutral |
| Stochastic | 65.0 | Neutral |
THO's weekly RSI is 51 (neutral) and its Stochastic is 65 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over THO on valuation relative to its sector.
THO PE vs Consumer Cyclical Sector
| Metric | THO | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 18x | 27% above |
| PE % | 82 | 47 | 35 pts above |
THO is trading at 23x earnings, a 27% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over THO on trend strength, trading above more of its moving averages.
THO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $72.0 | 7.3% above |
| 20 week MA | $74.3 | 4% above |
| 50 week MA | $84.6 | 8.7% below |
| 100 week MA | $89.2 | 13% below |
| 200 week MA | $94.8 | 19% below |
THO has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 19% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over THO on returns for 2026, with the stronger performance.
THO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $74.4 | $102.4 | +38% |
| 2021 | $102.4 | $100.9 | -1.5% |
| 2022 | $100.9 | $77.3 | -23% |
| 2023 | $77.3 | $118.3 | +53% |
| 2024 | $118.3 | $95.4 | -19% |
| 2025 | $95.4 | $106.2 | +11% |
| 2026 YTD | $106.2 | $77.3 | -27% |
THO has finished lower in three of the last six years. It's down 27% so far in 2026.